Business Wire

20th Anniversary of UltraDNS Celebrated by Neustar

Share

Neustar®, Inc., a trusted, neutral provider of real-time information services, today celebrated the 20th anniversary of UltraDNS®, its signature Authoritative DNS Service. Created in 1998 by Rodney Joffe, senior vice president and Neustar fellow, UltraDNS was the first DNS service to leverage IP Anycast technology, enabling it to be faster, safer and more resilient to distributed denial of service (DDoS) attacks and other online threats.

Today, UltraDNS is trusted by brands and organisations across the globe to keep their digital presence online and secure. Over the years UltraDNS has played a significant role in defending against many would-be crippling DDoS attacks, cementing its place as a critical technology to protect a brand’s infrastructure. "These types of attacks have been a persistent threat over the last few decades and highlighted the importance of DNS to the internet," said Rodney Joffe.

"From Trinoo and Stacheldraht in the late 90s, to Mirai and its assorted iterations that have plagued brands in the last few years, attackers continue to probe and breach defences. The internet has become fundamental to every organisation’s day to day operations, and without DNS, there is no internet and no digital presence," noted Joffe.

In addition to withstanding otherwise debilitating DDoS attacks, UltraDNS has a long history of pioneering innovations and a number of industry firsts, such as being:

  • The first DNS service to leverage proprietary code, which unlike BIND-based services, is not open-sourced;
  • The first DNS service protected by a built-in DDoS mitigation service - now known as Neustar SiteProtect NG®;
  • The first DNS service to offer an entirely segregated and securely sealed DNS environment using the award winning, DNS Shield™.

One of Neustar’s customers is Yorkshire Building Society Group (YBS) in the U.K. Andrew Winkless, infrastructure manager at YBS commented, “If our customers are unable to access our online services and our emails are down, our productivity comes to a halt. It’s vital we have a DNS provider that we can rely on to help us prevent that from happening. Neustar UltraDNS ticks all of the right boxes, keeping the group online and our customers happy.”

"UltraDNS has evolved and improved as part of our commitment to providing our customers – and our customers’ customers – with a flawless digital experience," continued Joffe. "As attackers continue to find new and creative ways to launch their assaults, we'll continue to innovate to stay ahead of the game, continuously keeping our customer's DNS secure."

As part of its commitment to maintaining the premier status of UltraDNS as a world-class DNS service, Neustar has already added additional DNS nodes to its SiteProtect NG network in North America, Europe and Asia in 2018, to provide greater scalability in the future. With more nodes slated for 2018 in South America, Africa, Australia and the Indian subcontinent, Neustar continues to actively expand the footprint of UltraDNS across the globe to provide faster and safer online experiences.

For more information about the Neustar UltraDNS solution, please visit: https://www.security.neustar/dns-services.

About Neustar Security Solutions

Neustar Security Solutions defend against network threats, inform you of potential network vulnerabilities, accelerate online asset performance, and monitor client website performance through multiple services and offerings. Neustar’s industry leading SiteProtect NG DDoS defense service ensures full layered coverage in an attack. Neustar UltraDNS service manages 10% of all internet traffic, routes over 1 trillion queries a month and provides industry leading uptime with 100% availability. Neustar IP Intelligence is the authoritative source of IP decisioning data on 99.99% of routable IP addresses worldwide. Our nearly 20 years of unparalleled expertise ensures that our customers are protected and optimized during normal business practices and when unsolicited events occur. Our services ensure customers network connectivity are protected and optimized whether in crisis or just business as usual. We are trusted by many of the world’s largest brands to keep their mission critical systems up and running. More information is available at https://www.security.neustar.

About Neustar

Neustar, Inc. is a leading global information services provider driving the connected world forward with trusted, holistic identity resolution. As the only company capable of understanding who is on the other end of every interaction, Neustar is trusted by the world’s great brands to grow and guard their businesses with the most complete understanding of how to connect people, places and things. The combination of Neustar’s unique, accurate, and real-time identity system and our cloud-based workflow solutions empower our clients to make actionable, precise and valuable decisions across marketing, risk, IT/security, network and operations departments. More information is available at https://www.home.neustar.

Contact information

Neustar Media Contact
Hannah Lock
Hotwire Global (on behalf of Neustar)
neustar@hotwireglobal.com
+44 07393 465 537

About Business Wire

Business Wire
Business Wire
24 Martin Lane
EC4R 0DR London

+44 20 7626 1982http://www.businesswire.co.uk

(c) 2018 Business Wire, Inc., All rights reserved.

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

IDEMIA Will Present Its H1 2019 Financial Results to Investors on July 30, 201923.7.2019 07:00:00 CESTPress release

IDEMIA, the world leader in Augmented Identity, today announced that it will present its H1 2019 financial results to investors on Tuesday July 30, 2019. Yann Delabrière (CEO) and Laurent Lemaire (CFO) will be presenting the financial results and taking questions the same day at 3:30 pm CET (2:30 pm London Time / 9:30 am New York Time). For more information, please refer to our website: https://investors.idemia.com/ About IDEMIA IDEMIA, the global leader in Augmented Identity, provides a trusted environment enabling citizens and consumers alike to perform their daily critical activities (such as pay, connect and travel), in the physical as well as digital space. Securing our identity has become mission critical in the world we live in today. By standing for Augmented Identity, an identity that ensures privacy and trust and guarantees secure, authenticated and verifiable transactions, we reinvent the way we think, produce, use and protect one of our greatest assets – our identity – whet

Gain Therapeutics SA Announces Award Notification of a €1.4M Grant Support From Eurostars-2 Together With the Institute for Research in Biomedicine and Neuro-Sys SAS After Having Scored 2nd Among 325 Eligible Applications23.7.2019 06:30:00 CESTPress release

Gain Therapeutics SA, a biotechnology company discovering and developing novel therapeutics to target lysosomal enzymes involved in inborn errors of metabolism and in central nervous system (CNS) diseases, today announced that together with Dr. Maurizio Molinari from the Institute for Research in Biomedicine, Bellinzona (Switzerland) affiliated to the Università della Svizzera italiana (USI) and Neuro-Sys SAS in Gardanne (France), it has received funding support from Eurostars-2 joint programme with co-funding from the European Union Horizon 2020 research and Innosuisse – Swiss Innovation Agency. This grant will further strengthen Gain Therapeutics’s novel therapeutic approach for targeting rare diseases in the CNS, where lysosomal misfolded enzymes lead to sever clinical phenotypes, where no treatment is available and/or high unmet medical needs still do afflict patients, families and carers. This funding will support the development of the drugs portfolio of Gain Therapeutics for the

iBASIS Accelerates Growth With JC Geha as Chief Operating Officer23.7.2019 06:00:00 CESTPress release

iBASIS, provider of communications solutions for operators and digital players worldwide, today announced the appointment of JC Geha as its COO. He will take his new post effective August 1, and be based at iBASIS’ headquarters in Lexington, Massachusetts. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190722005757/en/ JC Geha (Photo: Business Wire) Formerly Senior Vice President, Head of International Technology and Services for Deutsche Telekom, and of Managed Services for Ericsson, Geha brings to iBASIS an impressive track record of profitable growth, technology and digital transformation expertise. His expertise spans 25 years of deep global industry relationships across the United States, Europe, Middle East, and Africa. Geha will lead iBASIS’ global operations, engineering, IT, and product development. He will report to iBASIS’ CEO and founder of the Group Tofane Global, Alexandre Pébereau, with the responsibility of g

Abzena Announces Successful Technical Transfer of Synaffix GlycoConnect™ Antibody Drug Conjugate (ADC) Technology to Enable Use in Client Projects23.7.2019 06:00:00 CESTPress release

Abzena, the global partner research organization, announced it has successfully completed a technology transfer and scalability evaluation using the Synaffix technologies of GlycoConnect™ (antibody conjugation) and HydraSpace™ (highly polar spacer). Familiarity with these Antibody-Drug Conjugate (ADC) technologies adds to Abzena’s leadership in process development and GMP manufacturing of ADC linkers and payloads. Abzena can now rapidly ramp up ADC projects using Synaffix technology with high scientific quality. Jonathan Goldman, MD, Abzena CEO added: “Abzena believes in patient first drug development. Our expertise and experience with Synaffix GlycoConnect™ and HydraSpace™ technology further advances our leadership across multiple platforms in ADC. We look forward to supporting our customers as they leverage Synaffix technology to rapidly advance ADCs from IND stage into early clinical development.” About Abzena Abzena provides the most complete set of solutions in integrated discover

Aroma Bit to Develop Smartphone Embeddable Ultra-compact Silicon CMOS Based Smell Sensor That Has Dog Nose Equivalent Resolution in 1mm Squared Die Size23.7.2019 01:30:00 CESTPress release

Aroma Bit launched a new subsidiary to develop the next generation smell sensor based on silicon CMOS sensor substrate that are ultra-compact, high resolution and low cost. The technology is realized by applying Aroma Bit developed smell sensor receptor membrane technology to ultra-sensitive silicon CMOS based ion imaging sensor technology developed by professor Kazuaki Sawada at Toyohashi University of Technology and associated companies. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190722005004/en/ Picture of 1mm squared die of silicon CMOS based smell sensor, with dog nose equivalent ~1,200 sensor pixels (Photo: Business Wire) Aroma Bit: http://www.aromabit.com Realizing smartphone embeddable smell sensor with dog nose equivalent ultra-high resolution smell sensor on only 1 millimeter square silicon die size Aroma Bit has developed and are currently selling a compact smell sensor that employs QCM or Quartz Crystal Micro

Logitech Delivers a Strong Start to Fiscal Year 2020 with Robust Sales and Profit Growth23.7.2019 01:00:00 CESTPress release

Logitech International (SIX: LOGN) (Nasdaq: LOGI) today announced financial results for the first quarter of Fiscal Year 2020. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190722005781/en/ Logitech delivers a strong start to Fiscal Year 2020 with robust sales and profit growth. (Graphic: Business Wire) Q1 sales were $644 million, up 6 percent in US dollars and 9 percent in constant currency, compared to Q1 of the prior year. Q1 GAAP operating income grew 46 percent to $47 million, compared to $32 million in the same quarter a year ago. Q1 GAAP earnings per share (EPS) grew 17 percent to $0.27, compared to $0.23 in the same quarter a year ago. Q1 non-GAAP operating income grew 11 percent to $67 million, compared to $61 million in the same quarter a year ago. Q1 non-GAAP EPS grew 15 percent to $0.39, compared to $0.34 in the same quarter a year ago. Cash flow from operations was $37 million, compared to $12 million in the sa